1. Home
  2. MPB vs CMPX Comparison

MPB vs CMPX Comparison

Compare MPB & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mid Penn Bancorp

MPB

Mid Penn Bancorp

HOLD

Current Price

$32.43

Market Cap

856.0M

Sector

Finance

ML Signal

HOLD

Logo Compass Therapeutics Inc.

CMPX

Compass Therapeutics Inc.

HOLD

Current Price

$1.90

Market Cap

927.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MPB
CMPX
Founded
1868
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
856.0M
927.5M
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
MPB
CMPX
Price
$32.43
$1.90
Analyst Decision
Buy
Strong Buy
Analyst Count
1
9
Target Price
$37.00
$14.57
AVG Volume (30 Days)
101.9K
11.9M
Earning Date
04-21-2026
05-06-2026
Dividend Yield
2.66%
N/A
EPS Growth
N/A
N/A
EPS
0.36
N/A
Revenue
N/A
N/A
Revenue This Year
$30.95
N/A
Revenue Next Year
$9.45
$934.41
P/E Ratio
$87.92
N/A
Revenue Growth
N/A
N/A
52 Week Low
$25.83
$1.61
52 Week High
$35.22
$6.88

Technical Indicators

Market Signals
Indicator
MPB
CMPX
Relative Strength Index (RSI) 48.00 28.81
Support Level $30.25 $1.61
Resistance Level $34.88 $3.54
Average True Range (ATR) 0.79 0.14
MACD -0.11 0.10
Stochastic Oscillator 45.86 53.15

Price Performance

Historical Comparison
MPB
CMPX

About MPB Mid Penn Bancorp

Mid Penn Bancorp Inc is a financial holding company, providing various banking and financial products and services through its subsidiaries. These products and services mainly include consumer banking products, including secure checking and savings accounts, mobile banking, agricultural loans, construction financing, mortgages, home equity loans and lines of credit, credit cards, and more. Additionally, the Group offers trust services, insurance products, wealth management, and private banking services. The Group caters to individuals, partnerships, non-profit organizations, and corporations through its retail banking offices located throughout Pennsylvania, with a minor portion in New Jersey.

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage oncology-focused biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to target the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-A, Bispecific, and CTX-8371.

Share on Social Networks: